GCSAM
Basic information
Region (hg38): 3:112120839-112133270
Previous symbols: [ "GCET2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GCSAM gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 9 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 9 | 0 | 0 |
Variants in GCSAM
This is a list of pathogenic ClinVar variants found in the GCSAM region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-112123498-C-T | not specified | Likely benign (Mar 15, 2024) | ||
3-112123499-G-A | not specified | Uncertain significance (Apr 07, 2022) | ||
3-112123514-A-G | not specified | Uncertain significance (Apr 24, 2024) | ||
3-112123550-A-T | not specified | Uncertain significance (Feb 12, 2024) | ||
3-112123556-C-T | not specified | Uncertain significance (Nov 09, 2024) | ||
3-112123565-A-T | not specified | Uncertain significance (Apr 08, 2024) | ||
3-112123586-T-C | not specified | Uncertain significance (Oct 30, 2023) | ||
3-112123594-A-G | not specified | Uncertain significance (Nov 07, 2024) | ||
3-112123645-C-G | not specified | Uncertain significance (Nov 22, 2021) | ||
3-112123718-G-A | not specified | Uncertain significance (Mar 25, 2024) | ||
3-112123724-T-C | not specified | Uncertain significance (Oct 24, 2024) | ||
3-112123754-A-C | not specified | Uncertain significance (Jun 28, 2023) | ||
3-112125234-G-T | not specified | Uncertain significance (Dec 27, 2022) | ||
3-112127027-T-A | not specified | Uncertain significance (Aug 28, 2023) | ||
3-112128042-C-T | not specified | Uncertain significance (Jul 25, 2023) | ||
3-112130471-C-T | not specified | Uncertain significance (Oct 05, 2023) | ||
3-112130512-G-A | not specified | Likely benign (Dec 10, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GCSAM | protein_coding | protein_coding | ENST00000484193 | 6 | 12465 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0640 | 0.877 | 125669 | 0 | 10 | 125679 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.491 | 83 | 96.6 | 0.859 | 0.00000485 | 1182 |
Missense in Polyphen | 33 | 37.956 | 0.86942 | 506 | ||
Synonymous | -0.275 | 33 | 31.0 | 1.06 | 0.00000142 | 322 |
Loss of Function | 1.59 | 3 | 7.78 | 0.385 | 3.31e-7 | 86 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000441 | 0.0000440 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000179 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the negative regulation of lymphocyte motility. It mediates the migration-inhibitory effects of IL6. Serves as a positive regulator of the RhoA signaling pathway. Enhancement of RhoA activation results in inhibition of lymphocyte and lymphoma cell motility by activation of its downstream effector ROCK. Is a regulator of B-cell receptor signaling, that acts through SYK kinase activation. {ECO:0000269|PubMed:17823310, ECO:0000269|PubMed:20844236, ECO:0000269|PubMed:23299888}.;
Recessive Scores
- pRec
- 0.0733
Intolerance Scores
- loftool
- rvis_EVS
- -0.45
- rvis_percentile_EVS
- 24
Haploinsufficiency Scores
- pHI
- 0.0302
- hipred
- N
- hipred_score
- 0.172
- ghis
- 0.595
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gcsam
- Phenotype
- immune system phenotype;
Gene ontology
- Biological process
- regulation of B cell receptor signaling pathway;negative regulation of lymphocyte migration
- Cellular component
- cytoplasm;plasma membrane
- Molecular function
- actin binding;protein binding;protein kinase binding;myosin II binding